Crossmark

Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin

Crossref DOI link: https://doi.org/10.1073/pnas.1619832114

Published Online: 2017-04-24

Published Print: 2017-05-09

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Liu, Kang

Lin, Fang-Tsyr

Graves, Joshua D.

Lee, Yu-Ju

Lin, Weei-Chin
Funding

Funding for this research was provided by:

HHS | NIH | National Cancer Institute (RO1CA100857)

HHS | NIH | National Cancer Institute (RO1CA138641)

HHS | NIH | National Cancer Institute (RO1CA203824)

DOD | Congressionally Directed Medical Research Programs (W81XWH-14-1-0339)

DOD | Congressionally Directed Medical Research Programs (W81XWH-14-1-0306)

Marsha Rivkin Center for Ovarian Cancer Research (Rivkin Center for Ovarian Cancer Pilot Award)
License Information

Version of Record valid from 2017-10-24
More Information

Publication History

Published: 2017-04-24